About the Authors
- Mathew B. Abrams
-
* E-mail: mathew.abrams@ki.se
Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Ingrid Nilsson
-
Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- Sebastian A. Lewandowski
-
Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- Jacob Kjell
-
Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Simone Codeluppi
-
Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Lars Olson
-
Affiliation Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Ulf Eriksson
-
Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Competing Interests
The authors have read the journal’s policy and have the following conflict: Ulf Eriksson and Ludwig Institute of Cancer Research (LICR) have submitted a patent application on the use of imatinib in CNS injuries (US patent 20070265203, filed 17 Apr 2007, published 15 Nov 2007). Lars Olson has received financial support from AFA Insurance company. Neither alters the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MBA IN LO UE. Performed the experiments: MBA SC. Analyzed the data: MBA IN SAL. Contributed reagents/materials/analysis tools: LO UE. Wrote the paper: MBA IN LO UE.